NEW YORK CITY, NY / ACCESS Newswire / February 12, 2025 / WHY: New York, N.Y., February 12, 2025. Rosen Law Firm, a global investor rights law ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Royalty Pharma (RPRX – Research Report), ...

Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies. You can obtain detailed information about the use of cookies ...

Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...

Class A shares underperformed the MSCI ACWI ex USA Index. During the quarter, we initiated four new positions and exited one ...

Brandscouncil Ratings felicitated 100+ Corporates with World Best Brands & Business Awards'2024, World Real Estate, ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” fourth-quarter 2024 investor letter. A ...

Artificial intelligence is rapidly evolving and is shaping industries and global competition. Companies are developing ... clinical development for pharmaceutical, biotechnology, and medical device ...

Baron Small Cap Fund declined in Q4 2024. Who were the top contributors and detractors? Click here to find out.

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical ... like the EU and China, companies are increasingly partnering with CROs that excel at navigating the evolving global regulatory landscape.

Chief executives of global companies left their jobs in record numbers last year, pushed by intense scrutiny from investors and pressure to keep up with change, according to leadership advisory ...

According to Robert F. Kennedy Jr.’s book, “The Real Anthony Fauci,” Dr. Fauci has altered the study protocols to give his pet drug “remdesivir,” which RFK states has proved worthless against COVID-19 ...